Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Oct 2026 for Mitie Group PLC, €4,301.
Filing timeline
BuySaleSalma Shah
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Closed purchases
Market purchases
21
Positive at T+90
65%
Median T+90
+1.7%
Based on 17 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +38.1%Entry £1.52 · Close 30 Sept 2026 £2.10
- +22.0%Entry £1.72 · Close 30 Sept 2026 £2.10
- +16.7%Entry £1.80 · Close 30 Sept 2026 £2.10
- +22.4%Entry £1.72 · Close 30 Sept 2026 £2.10
- +52.2%Entry £1.38 · Close 30 Sept 2026 £2.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Salma Shah: trading record in brief
Salma Shah discloses dealings in Mitie Group PLC to RNS (LSE). In total, 22 filings cover trades dated from 3 October 2022 to 1 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Ninety days after publication, 17 purchases show a median change of +1.7%, with the price up in 65% of them. Past outcomes like these are no guarantee of what comes next.
Most recently, on 1 October 2026, the filings show a share grant worth €4,301 in Mitie Group PLC. The median gap between a trade and its publication by RNS (LSE) is 1 day. For comparison, UK MAR gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Salma Shah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
1,744 shares@ £2.1055XLONISIN GB0004657408FCA-NSM:a73bdf7d-7a00-447b-a9d5-ec68d7e071e0-1
Canonical exit: 30 Dec 2026 (T+90)
578 shares@ £2.0880.0000% mcap2.9% of flowXLONISIN GB0004657408FCA-NSM:07cb26a3-c914-4fec-8041-d299e1478425-0
Canonical exit: 25 Nov 2026 (T+90)
2,220 shares@ £1.491689.1% of flowXLONISIN GB0004657408RNS:9648163-1
Canonical exit: 29 Sept 2026 (T+90)
2,220 shares@ £1.49160.0001% mcap8.0% of flowXLONISIN GB0004657408RNS:095d83aa-78e4-4fe1-b1b7-5e98ff18e3b7-1
Canonical exit: 29 Sept 2026 (T+90)
1,929 shares@ £1.72940.0001% mcap7.9% of flowXLONISIN GB0004657408RNS:c4ae2cde-4310-419c-a751-5186fed9f542-1
Canonical exit: 30 Jun 2026 (T+90)
264 shares@ £1.8341.1% of flowXLONISIN GB0004657408RNS:8a3dfdf4-306d-43a5-b317-35466a049951-0
Canonical exit: 21 May 2026 (T+90)
1,994 shares@ £1.67277.9% of flowXLONISIN GB0004657408RNS:8a0b59f4-7cd4-486b-996f-e0c96236e90b-1
Canonical exit: 2 Apr 2026 (T+90)
2,423 shares@ £1.37697.9% of flowXLONISIN GB0004657408RNS:5844283-1
Canonical exit: 30 Dec 2025 (T+90)
566 shares@ £1.45342.0% of flowXLONISIN GB0004657408RNS:5774177-0
Canonical exit: 4 Nov 2025 (T+90)
2,360 shares@ £1.41348.0% of flowXLONISIN GB0004657408RNS:5720134-2
Canonical exit: 29 Sept 2025 (T+90)
2,726 shares@ £1.1557.8% of flowXLONISIN GB0004657408RNS:5601516-2
Canonical exit: 30 Jun 2025 (T+90)
247 shares@ £1.15720.7% of flowXLONISIN GB0004657408RNS:5529754-0
Canonical exit: 6 May 2025 (T+90)
2,510 shares@ £1.10536.9% of flowXLONISIN GB0004657408RNS:5486941-2
Canonical exit: 2 Apr 2025 (T+90)
2,335 shares@ £1.1886.9% of flowXLONISIN GB0004657408RNS:5372603-2
Canonical exit: 30 Dec 2024 (T+90)
441 shares@ £1.16181.2% of flowXLONISIN GB0004657408RNS:5297954-0
Canonical exit: 3 Nov 2024 (T+90)
2,360 shares@ £1.17566.8% of flowXLONISIN GB0004657408RNS:5247557-2
Canonical exit: 29 Sept 2024 (T+90)
2,602 shares@ £1.06626.7% of flowXLONISIN GB0004657408RNS:5126558-2
Canonical exit: 1 Jul 2024 (T+90)
111 shares@ £1.03390.3% of flowXLONISIN GB0004657408RNS:5056745-0
Canonical exit: 30 Apr 2024 (T+90)
2,780 shares@ £0.9986.6% of flowXLONISIN GB0004657408RNS:5020047-2
Canonical exit: 1 Apr 2024 (T+90)
2,179 shares@ £1.0345.4% of flowXLONISIN GB0004657408RNS:4920724-2
Canonical exit: 31 Dec 2023 (T+90)
2,055 shares@ £0.96964.8% of flowXLONISIN GB0004657408RNS:4827710-2
Canonical exit: 4 Oct 2023 (T+90)
21 of 21 declarations
